Call for papers: AI in biochar research for sustainable land ecosystems
Business Announcement
This month, we’re focusing on artificial intelligence (AI), a topic that continues to capture attention everywhere. Here, you’ll find the latest research news, insights, and discoveries shaping how AI is being developed and used across the world.
Updates every hour. Last Updated: 27-Jan-2026 18:11 ET (27-Jan-2026 23:11 GMT/UTC)
Automated machine learning can accurately identify two types of benign tumors that develop in the same space within the brain
The accelerated evolution of space technology has elevated the importance of high power and lightweight attributes in satellite design. In response to the conflict between the demand for large-scale, high-power payloads and the need for lightweight, compact platforms, flexible space origami membrane structures have emerged as a potential solution. These structures possess the ability to overcome the limitations of traditional deployable mechanisms. Their geometric reconfiguration capabilities, characterized by high folding ratios, effectively satisfy the high-power performance demands.
CAMBRIDGE, Mass., January 23, 2026 --- Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), today announced that ISM8969, an orally available NLRP3 inhibitor targeting inflammation and neurodegenerative disorders, has recently received investigational new drug (IND) clearance from the U.S. Food and Drug Administration (FDA), intended for the treatment of Parkinson’s Disease.
Secondary lymphedema, a chronic condition caused by lymph node removal during cancer surgery, leads to swelling, pain, and reduced mobility with limited treatment options. In a recent study, researchers from Japan developed a centrifugal cell stacking technique to create artificial lymphatic tissues that can restore lymphatic flow. When transplanted into mice, CeLyTs form functional lymph node-like structures that reduce swelling and promote lymph flow, offering a promising therapeutic strategy for lymphedema.
Intelligent Medicine has been named to the 2025 list of China’s Internationally Influential Excellent Academic Journals, ranking 66th nationwide. The recognition underscores the journal’s rising international visibility and influence at the intersection of artificial intelligence, data science, digital technology, and clinical medicine.
In an era when artificial intelligence (AI) is touted as a disruptor of education, a series of landmark studies from the Shanghai Institute of Artificial Intelligence for Education, East China Normal University (ECNU), captures a more human-focused course. Published in a special issue of ECNU Review of Education, these four research projects, grounded in empirical data, deploys AI not to replace the human elements of teaching and learning, but to fundamentally understand and enhance them.